Skip to main content

Advertisement

SpringerLink
Log in

Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc

  • Original Article
  • Published:
Inflammopharmacology Aims and scope Submit manuscript

Abstract

Purpose of the research

In this study, we appraised the effect of pre-treatment with intra-cerebro ventricular (i.c.v) microinjection of gastrodin (Gst) on catalepsy, motor imbalance, substantia nigra pars compacta (SNc) myeloperoxidase (MPO) activity, lipid peroxidation levels, nitric oxide (NO) production and total antioxidant capacity (TAC) in 6-hydroxydopamine (6-OHDA) rats model of PD.

Materials and methods

Male Wistar rats were pre-treated with i.c.v microinjections of Gst (20, 40 and 80 μg/3 μl/rat) for five consecutive days. Then, catalepsy and motor balance were induced by unilateral infusion of 6-OHDA (8 μg/2 μl/rat) into the SNc. The anti-cataleptic and motor balance improving effect of Gst was assessed by the Bar test and Rotarod 3 weeks after neurotoxin injection, respectively. SNc MPO activity and lipid peroxidation levels, NO production and TAC were assessed at the end of behavioral experiments.

Results

Our data demonstrated that Gst pre-treatment significantly (p < 0.001) was prevented motor in-coordination and catalepsy in neurotoxin lesioned rats. The most motor improving effect was seen at 80 μg Gst (p < 0.001). Pre-treatment of parkinsonian rats with Gst meaningfully (p < 0.001) was suppressed MPO activity, lipid peroxidation and NO production. Furthermore, the TAC level in the SNc was increased (p < 0.001) in Gst-microinjected rats about to the normal non-parkinsonian animals.

Major conclusions

In summary, pre-treatment with Gst abolished 6-OHDA-induced catalepsy and improved motor incoordination by decreasing: SNc MPO activity, lipid peroxidation levels and NO production, and restoring SNc levels of TAC to the levels of healthy rats.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  • Benzie IF, Strain J (1999) [2] Ferric reducing/antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol 299:15–27

    Article  CAS  Google Scholar 

  • Blesa J, Trigo-Damas I, Quiroga-Varela A, Jackson-Lewis VR (2015) Oxidative stress and Parkinson’s disease. Front Neuroanat 9:91

    PubMed  PubMed Central  Google Scholar 

  • Block M, Hong J (2007) Chronic microglial activation and progressive dopaminergic neurotoxicity. Biochem Soc Trans 35:1127–1132

    Article  CAS  Google Scholar 

  • Blum D, Torch S, Lambeng N, Nissou M-F, Benabid A-L, Sadoul R, Verna J-M (2001) Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson’s disease. Prog Neurobiol 65:135–172

    Article  CAS  Google Scholar 

  • Choi DK et al (2005) Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson’s disease in mice. J Neurosci 25:6594–6600

    Article  CAS  Google Scholar 

  • Cohen G (1994) Free radicals, oxidative stress and neurodegeneration. In: Calne DB (ed) Neurodegenerative diseases. W. B Saunders, Philadelphia, pp 139–161

    Google Scholar 

  • Cohen G (2000) Oxidative stress, mitochondrial respiration, and Parkinson’s disease. Ann N Y Acad Sci 899:112–120

    Article  CAS  Google Scholar 

  • Dai J-N et al (2011) Gastrodin inhibits expression of inducible NO synthase, cyclooxygenase-2 and proinflammatory cytokines in cultured LPS-stimulated microglia via MAPK pathways. PLoS ONE 6:e21891

    Article  CAS  Google Scholar 

  • de Lau LM, Breteler M (2006) Epidemiology of Parkinson’s disease. Lancet Neurol 5:525–535

    Article  Google Scholar 

  • Dexter DT, Jenner P (2013) Parkinson disease: from pathology to molecular disease mechanisms. Free Radic Biol Med 62:132–144. https://doi.org/10.1016/j.freeradbiomed.2013.01.018

    Article  PubMed  CAS  Google Scholar 

  • Doo A-R et al (2014) Gastrodia elata Blume alleviates L-DOPA-induced dyskinesia by normalizing FosB and ERK activation in a 6-OHDA-lesioned Parkinson’s disease mouse model. BMC Complement Altern Med 14:107

    Article  Google Scholar 

  • Green PS, Mendez AJ, Jacob JS, Crowley JR, Growdon W, Hyman BT, Heinecke JW (2004) Neuronal expression of myeloperoxidase is increased in Alzheimer’s disease. J Neurochem 90:724–733

    Article  CAS  Google Scholar 

  • Haddadi R, Mohajjel Nayebi A, Brooshghalan SE (2013) Pre-treatment with silymarin reduces brain myeloperoxidase activity and inflammatory cytokines in 6-OHDA hemi-parkinsonian rats. Neurosci Lett 555:106–111

    Article  CAS  Google Scholar 

  • Haddadi R, Nayebi AM, Farajniya S, Brooshghalan SE, Sharifi H (2014) Silymarin improved 6-OHDA-induced motor impairment in hemi-parkisonian rats: behavioral and molecular study DARU. J Pharm Sci 22:38

    Google Scholar 

  • Haddadi R, Brooshghalan SE, Farajniya S, Nayebi AM, Sharifi H (2015) Short-term treatment with silymarin improved 6-OHDA-induced catalepsy and motor imbalance in hemi-parkisonian rats. Adv Pharm Bull 5:463–469. https://doi.org/10.15171/apb.2015.063

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • He Y, Appel S, Le W (2001) Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res 909:187–193

    Article  CAS  Google Scholar 

  • Hwang O (2013) Role of oxidative stress in Parkinson’s disease. Exp Neurobiol 22:11–17

    Article  Google Scholar 

  • Iancu R, Mohapel P, Brundin P, Paul G (2005) Behavioral characterization of a unilateral 6-OHDA-lesion model of Parkinson’s disease in mice. Behav Brain Res 162:1–10

    Article  CAS  Google Scholar 

  • Ikawa M et al (2017) Dopaminergic neuronal oxidative stress is increased with disease progression in patients with Parkinson’s disease: a study with PET and SPECT: P4. 027

  • Jiang G, Hu Y, Liu L, Cai J, Peng C, Li Q (2014) Gastrodin protects against MPP+-induced oxidative stress by up regulates heme oxygenase-1 expression through p38 MAPK/Nrf2 pathway in human dopaminergic cells. Neurochem Int 75:79–88

    Article  CAS  Google Scholar 

  • Kheradmand A, Mohajjel Nayebi A, Jorjani M, Haddadi R (2016a) Effect of WR-1065 on 6-hydroxydopamine-induced catalepsy and IL-6 level in rats. Iran J Basic Med Sci 19:490–496

    PubMed  PubMed Central  Google Scholar 

  • Kheradmand A, Nayebi AM, Jorjani M, Khalifeh S, Haddadi R (2016b) Effects of WR1065 on 6-hydroxydopamine-induced motor imbalance: possible involvement of oxidative stress and inflammatory cytokines. Neurosci Lett 627:7–12. https://doi.org/10.1016/j.neulet.2016.05.040

    Article  PubMed  CAS  Google Scholar 

  • Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS (2000) Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci 20:6309–6316

    Article  CAS  Google Scholar 

  • Kumar H, Kim I-S, More SV, Kim B-W, Bahk Y-Y, Choi D-K (2013) Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson’s disease model. Evid-Based Complement Altern Med 2013:514095

    Article  Google Scholar 

  • Lefkowitz DL, Lefkowitz SS (2008) Microglia and myeloperoxidase: a deadly partnership in neurodegenerative disease. Free Radic Biol Med 45:726–731

    Article  CAS  Google Scholar 

  • Li C, Chen X, Zhang N, Song Y, Mu Y (2012) Gastrodin inhibits neuroinflammation in rotenone-induced Parkinson’s disease model rats. Neural Regen Res 7:325

    PubMed  PubMed Central  CAS  Google Scholar 

  • Liu B, Hong JS (2003) Role of microglia in inflammation-mediated neurodegenerative diseases: mechanisms and strategies for therapeutic intervention. J Pharmacol Exp Ther 304:1–7

    Article  CAS  Google Scholar 

  • Loeffler DA, Klaver AC, Coffey MP, Aasly JO, LeWitt PA (2017) Increased oxidative stress markers in cerebrospinal fluid from healthy subjects with parkinson’s disease-associated LRRK2 gene mutations. Front Aging Neurosci 9:89

    Article  CAS  Google Scholar 

  • McGeer P, Itagaki S, Boyes B, McGeer E (1988) Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brains. Neurology 38:1285

    Article  CAS  Google Scholar 

  • Miranda KM, Espey MG, Wink DA (2001) A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric Oxide 5:62–71

    Article  CAS  Google Scholar 

  • Mosley RL et al (2006) Neuroinflammation, oxidative stress, and the pathogenesis of Parkinson’s disease. Clin Neurosci Res 6:261–281

    Article  CAS  Google Scholar 

  • Olson JK, Miller SD (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 173:3916–3924

    Article  CAS  Google Scholar 

  • Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Academic press, San Diego

    Google Scholar 

  • Peng Z et al (2015) Gastrodin alleviates cerebral ischemic damage in mice by improving anti-oxidant and anti-inflammation activities and inhibiting apoptosis pathway. Neurochem Res 40:661–673

    Article  CAS  Google Scholar 

  • Puthalakath H et al (2007) ER stress triggers apoptosis by activating BH3-only protein Bim. Cell 129:1337–1349

    Article  CAS  Google Scholar 

  • Reynolds WF, Rhees J, Maciejewski D, Paladino T, Sieburg H, Maki RA, Masliah E (1999) Myeloperoxidase polymorphism is associated with gender specific risk for Alzheimer’s disease. Exp Neurol 155:31–41

    Article  CAS  Google Scholar 

  • Schapira A, Cooper J, Dexter D, Clark J, Jenner P, Marsden C (1990) Mitochondrial complex I deficiency in Parkinson’s disease. J Neurochem 54:823–827

    Article  CAS  Google Scholar 

  • Sharifi H, Nayebi A, Farajnia S, Haddadi R (2014) Effect of chronic administration of buspirone and fluoxetine on inflammatory cytokines in 6-hydroxydopamine-lesioned rats. Drug Res. 64:1–5

    Article  Google Scholar 

  • Sharifi H, Nayebi AM, Farajnia S, Haddadi R (2015) Effect of buspirone, fluoxetine and 8-OH-DPAT on striatal expression of bax, caspase-3 and Bcl-2 proteins in 6-hydroxydopamine-induced hemi-Parkinsonian rats. Adv Pharm Bull 5:491

    Article  CAS  Google Scholar 

  • Song C, Fang S, Lv G, Mei X (2013) Gastrodin promotes the secretion of brain-derived neurotrophic factor in the injured spinal cord. Neural Regen Res 8:1383

    PubMed  PubMed Central  CAS  Google Scholar 

  • Sugama S et al (2003) Age-related microglial activation in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res 964:288–294

    Article  CAS  Google Scholar 

  • Tang W, Eisenbrand G (1992) Chinese drugs of plant origin. Chem Pharmacol Tradit Mod Med. https://doi.org/10.1007/978-3-642-73739-8

    Article  Google Scholar 

  • Zhang J-S, Zhou S-F, Wang Q, Guo J-N, Liang H-M, Deng J-B, He W-Y (2016) Gastrodin suppresses BACE1 expression under oxidative stress condition via inhibition of the PKR/eIF2α pathway in Alzheimer’s disease. Neuroscience 325:1–9

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology and Toxicology, School of Pharmacy, Hamadan University of Medical Sciences, Hamadan, Iran

    Rasool Haddadi & Fatemeh Zeraati

  2. Herbal Medicine and Natural Product Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

    Rasool Haddadi & Fatemeh Zeraati

  3. Students Research Center, Hamadan University of Medical Sciences, Hamadan, Iran

    Maryam Poursina & Forough Nadi

Authors
  1. Rasool Haddadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maryam Poursina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fatemeh Zeraati
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Forough Nadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rasool Haddadi.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Haddadi, R., Poursina, M., Zeraati, F. et al. Gastrodin microinjection suppresses 6-OHDA-induced motor impairments in parkinsonian rats: insights into oxidative balance and microglial activation in SNc. Inflammopharmacol 26, 1305–1316 (2018). https://doi.org/10.1007/s10787-018-0470-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10787-018-0470-4

Keywords

Search

Navigation